“Dangerous liaisons: NAFLD and liver fibrosis increase cardiovascular risk in HIV”
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
“Dangerous liaisons: NAFLD and liver fibrosis increase cardiovascular risk in HIV”
Authors
Keywords
-
Journal
HIV MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-02-24
DOI
10.1111/hiv.13274
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diabetes in People with HIV
- (2021) Sudipa Sarkar et al. Current Diabetes Reports
- Prevalence, predictors and severity of lean non-alcoholic fatty liver disease in HIV-infected patients
- (2020) Adriana Cervo et al. CLINICAL INFECTIOUS DISEASES
- Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
- (2020) Alessandro Mantovani et al. Metabolites
- Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Peter J. Eddowes et al. GASTROENTEROLOGY
- Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Co-Transporter 2 Inhibitors for Prevention of MajorAdverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials
- (2019) Thomas A. Zelniker et al. CIRCULATION
- Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association
- (2019) Matthew J. Feinstein et al. CIRCULATION
- Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis
- (2019) Oghenowede Eyawo et al. BMJ Open
- Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV ‐monoinfected patients
- (2019) G Sebastiani et al. HIV MEDICINE
- Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study
- (2019) Francesco Baratta et al. Clinical Gastroenterology and Hepatology
- Association of predicted 10 years cardiovascular mortality risk with duration of HIV infection and antiretroviral therapy among HIV-infected individuals in Durban, South Africa
- (2019) Olamide O. Todowede et al. Diabetology & Metabolic Syndrome
- Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection
- (2018) Virginia A. Triant et al. CIRCULATION
- Global Burden of Atherosclerotic Cardiovascular Disease in People Living with the Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis
- (2018) Anoop S. V. Shah et al. CIRCULATION
- Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis
- (2018) Cyrielle Caussy et al. HEPATOLOGY
- Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis
- (2018) Raphael Mohr et al. MEDICINE
- Prior exposure to thymidine analogues and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors
- (2018) Marco Gelpi et al. AIDS
- Diagnostic accuracy of noninvasive markers of steatosis, NASH and liver fibrosis in HIV-monoinfected individuals at-risk of non-alcoholic fatty liver disease (NAFLD)
- (2018) Maud Lemoine et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Experience of using ISGTL-2 in patients with DM2 and HIV infection
- (2017) M. Dolores García de Lucas et al. European Journal of Internal Medicine
- Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis
- (2017) Thomas Pembroke et al. JOURNAL OF HEPATOLOGY
- Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
- (2017) Jürgen Kurt Rockstroh Current HIV/AIDS Reports
- Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients
- (2016) Élise Vuille-Lessard et al. AIDS
- Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease
- (2016) Victor de Lédinghen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
- (2016) Amedeo Lonardo et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis
- (2016) Jason H Y Wu et al. Lancet Diabetes & Endocrinology
- Transient elastography for the detection of hepatic fibrosis in HIV-monoinfected adults with elevated aminotransferases on antiretroviral therapy
- (2015) Caryn G. Morse et al. AIDS
- HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review
- (2015) CT Lambert et al. HIV MEDICINE
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
- (2014) Colette J Smith et al. LANCET
- Sudden Cardiac Death in Patients With Human Immunodeficiency Virus Infection
- (2012) Zian H. Tseng et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients
- (2011) Maud Lemoine et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Liver Disease in the HIV–Infected Individual
- (2010) Jennifer C. Price et al. Clinical Gastroenterology and Hepatology
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Amy G. Shah et al. Clinical Gastroenterology and Hepatology
- Nonalcoholic Fatty Liver Disease in HIV‐Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors
- (2008) Giovanni Guaraldi et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started